로딩 중…
지수 로딩 중…
Aquestive Therapeutics, Inc.
AQST· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$4.71+6.32%
2026-06-18
Price Chart
Aquestive Therapeutics, Inc.+38.53%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $591M |
| Revenue | $50M |
| Net Income | $-69M |
| Total Assets | $141M |
| Net Assets | $-34M |
| Value | |
| P/S | 11.75x |
| FCF Yield | -7.50% |
| Profitability | |
| ROA | -48.83% |
| Op. Margin | -111.18% |
| Revenue Growth | 65.67% |
| Financial Health | |
| Total Debt | $134M |
| FCF | $-44M |
| Cash | $111M |
| Current Ratio | 4.10x |
| Performance | |
| 1Y Return | 38.53% |
| 1M Return | 15.16% |
| From 52W High | -37.62% |
| 1Y MDD | -60.61% |
| Trading | |
| Volume | 2,972,687 shares |
| Trading Value | $14M |
| Per Share | |
| EPS | $-0.69 |